Why is Bruker Corp. ?
- OPERATING CASH FLOW(Y) Lowest at USD 134.1 MM
- ROCE(HY) Lowest at -0.4%
- RAW MATERIAL COST(Y) Grown by 9.14% (YoY)
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -19.53%, its profits have risen by 11.7% ; the PEG ratio of the company is 2.9
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 6.77% over the previous quarter.
- Along with generating -19.53% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Bruker Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bruker Corp. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
The company hardly has any interest cost
Lowest at 63.48 %
Highest at 1.69 times
Highest at 5.52 times
Highest at USD 152 MM
Highest at 15.55 %
Highest at USD 85.8 MM
At USD 33.85 MM has Grown at 76.37%
Lowest at USD 134.1 MM
Lowest at -0.4%
Grown by 9.14% (YoY
Here's what is working for Bruker Corp.
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Debt-Equity Ratio
Inventory Turnover Ratio
Debtors Turnover Ratio
Depreciation (USD MM)
Here's what is not working for Bruker Corp.
Operating Cash Flows (USD MM)
Raw Material Cost as a percentage of Sales






